Filing Analysis
MicroVision, Inc. completed a public offering of 6.8 million shares of common stock and 6.8 million warrants at a combined price of $2.50 per share. The offering raised approximately $15.6 million in net proceeds to be used for general corporate purposes, including working capital and capital expenditures.
🚩 Red Flags
- Potential dilution for existing shareholders due to the issuance of 6.8 million new shares and 6.8 million warrants.
- Warrants are exercisable immediately, which can lead to rapid downward pressure on the stock price upon exercise.
- The company is raising capital for 'working capital and capital expenditures,' suggesting a need for liquidity to fund ongoing operations.
📋 Key Facts
- Offered 6,800,000 shares of common stock and 6,800,000 warrants.
- Combined offering price: $2.50 per share and warrant.
- Warrants have an exercise price of $2.50, are exercisable immediately, and expire in five years.
- Net proceeds estimated at approximately $15.6 million.
- WestPark Capital, Inc. acted as placement agent with a 6.5% cash fee.
- The offering included a 45-day stand-still provision regarding the issuance of additional securities or repayments on senior secured convertible notes.
- Offering closed on August 17, 2026.
MicroVision, Inc. announced the appointment of Christine Chambers as Chief Financial Officer, effective August 27, 2026. This transition involves the conclusion of Stephen Hrynewich's tenure as Interim CFO, who will remain with the company in a senior finance role.
🚩 Red Flags
- None identified; the departure of the interim officer was explicitly stated as not being due to disagreements.
📋 Key Facts
- Christine Chambers appointed as CFO and principal financial/accounting officer, effective August 27, 2026.
- Ms. Chambers to receive an annual cash base salary of $425,000.
- Targeted annual incentive bonus of 65% of base salary (cash or RSUs).
- One-time new-hire equity award of $1,000,000 in RSUs vesting over four years.
- Annual long-term equity incentive opportunity of $800,000 in RSUs vesting over three years.
- Stephen Hrynewich to cease serving as Interim CFO on August 27, 2026, but will continue in a senior finance role.
- The transition of the Interim CFO is not due to any disagreement with the Company.
MicroVision, Inc. filed an 8-K to announce its second quarter 2026 financial results via a press release. The filing contains no specific financial data in the text but serves as the formal vehicle for the earnings announcement.
📋 Key Facts
- Report date: August 6, 2026
- Company announced Q2 2026 results via press release (Exhibit 99.1)
- The information was furnished under Item 2.02 and is not deemed 'filed' for purposes of Section 18 liability.
MicroVision, Inc. has announced a 1-for-15 reverse stock split following shareholder approval at the annual meeting on July 10, 2026. The split is intended to consolidate shares and simultaneously reduce the total authorized number of capital stock shares.
🚩 Red Flags
- Reverse stock split (often used to maintain minimum bid price requirements for exchange compliance).
- Recent transfer of listing status (contextual indicator of regulatory/compliance pressure).
📋 Key Facts
- Reverse stock split ratio: 1-for-15 (every fifteen shares combined into one).
- Effective Time: August 1, 2026, at 5:00 p.m. ET.
- New trading begins on a split-adjusted basis on August 3, 2026, under symbol 'MVIS'.
- Total authorized shares reduced to 175,000,000 (150,000,000 Common, 25,000,000 Preferred).
- Fractional shares will be rounded up to the nearest whole share.
- The company recently transferred its listing to The Nasdaq Capital Market effective July 20, 2026.
MicroVision, Inc. held its annual meeting of shareholders on July 10, 2026, where shareholders approved several critical measures, including the authorization for a reverse stock split and the issuance of shares related to senior secured convertible notes.
🚩 Red Flags
- Approval of a reverse stock split (ratio 1-for-5 to 1-for-15) often indicates efforts to maintain Nasdaq listing compliance regarding minimum bid price requirements.
- Shareholders approved the issuance of shares related to senior secured convertible notes, which can lead to significant dilution for existing shareholders.
📋 Key Facts
- Annual meeting held on July 10, 2026; 214,190,090 shares (62% of Common Stock) represented in voting.
- All seven director nominees were elected to hold office until the next annual meeting.
- Shareholders approved issuance of common stock related to senior secured convertible notes issued on February 23, 2026.
- Shareholders approved amendments allowing a reverse stock split with a ratio between 1-for-5 and 1-for-15.
- The Board of Directors has one year from the meeting date to determine the exact ratio and timing of the potential reverse split.
- Baker Tilly US, LLP was ratified as the independent registered public accounting firm for FY2026.
MicroVision, Inc. has issued an 8-K to furnish a CEO Letter and Q&A document published on its website. This filing is intended to address topics raised during the company's virtual Business Update and Shareholder Q&A event held on June 25.
🚩 Red Flags
- None identified in the text provided; however, Regulation FD filings often follow periods of high market volatility or intense shareholder questioning.
📋 Key Facts
- The filing relates to a 'CEO Letter' and a series of Q&As released via the company's investor relations website.
- The disclosure follows a virtual Business Update and Shareholder Q&A event conducted on June 25, 2026.
- The information is furnished under Item 7.01 (Regulation FD) and is not considered 'filed' for purposes of Section 18 liability.
MicroVision, Inc. filed an 8-K to furnish investor presentation slides used during a virtual Business Update and Shareholder Q&A event held on June 25, 2026.
📋 Key Facts
- The company conducted a virtual Business Update and Shareholder Q&A event on June 25, 2026.
- Event slides were published on the company's investor relations website.
- The filing is made pursuant to Item 7.01 (Regulation FD) to ensure public access to information shared during the event.
MicroVision has applied to transfer its listing from the Nasdaq Global Market to the Nasdaq Capital Market to avoid delisting due to failure to maintain the $1.00 minimum bid price. Simultaneously, the company amended its At-The-Market (ATM) offering agreement to facilitate further equity sales.
🚩 Red Flags
- Failure to maintain minimum bid price of $1.00 (Minimum Bid Price Requirement).
- Down-tiering from Nasdaq Global Market to Nasdaq Capital Market is typically a sign of financial distress or declining market capitalization.
- Multiple 8-K items in a single filing (1.01, 3.01, 7.01), which is a severity escalator.
- Continued reliance on ATM equity offerings for capital, which causes shareholder dilution.
📋 Key Facts
- Applied for transfer to Nasdaq Capital Market on June 12, 2026, to address Minimum Bid Price Requirement (Rule 5450(a)(1)).
- If approved, the company may receive an additional 180-calendar-day grace period to regain compliance.
- Compliance requires the stock to close at $1.00 or more for at least 10 consecutive business days.
- Entered into Amendment No. 1 to the ATM Sales Agreement with Deutsche Bank, Mizuho, and Craig-Hallum.
- Approximately $42,000,000 of Common Stock remains unsold under the existing ATM agreement as of June 12, 2026.
MicroVision announced the signing of a Master Development Agreement, including an initial Program Description dated June 1, 2026. The company furnished a press release regarding this collaboration via a Regulation FD filing.
📋 Key Facts
- Master Development Agreement signed with an initial Program Description dated June 1, 2026.
- Announcement made via press release on June 10, 2026.
- The filing is furnished under Item 7.01 (Regulation FD), meaning it is not 'filed' for Section 18 liability purposes.
MicroVision announced its intention to seek shareholder approval to amend its certificate of incorporation, granting the Board of Directors the authority to execute a reverse stock split. The proposed ratio is between 1-for-5 and 1-for-15.
🚩 Red Flags
- Reverse stock splits are typically used by micro-cap companies to artificially inflate share prices to avoid delisting or to meet minimum bid requirements
- The wide range of the split ratio (1-for-5 to 1-for-15) provides significant discretion to the Board, which can be unpredictable for investors
📋 Key Facts
- Announcement date: June 1, 2026
- Proposed reverse split ratio: Not less than 1-for-5 and not more than 1-for-15
- Record date for shareholders: May 28, 2026
- The company has retained Saratoga Proxy Consulting LLC at an estimated cost of $10,000 plus expenses to assist in proxy solicitation
MicroVision, Inc. (MVIS) furnished its first quarter 2026 financial results on May 13, 2026. The filing includes the press release as Exhibit 99.1 and does not disclose any other material events.
📋 Key Facts
- MicroVision, Inc. issued a press release on May 13, 2026, announcing its first quarter 2026 results.
- The information was furnished under Item 2.02 (Results of Operations and Financial Condition).
- The filing includes Exhibit 99.1, which is the press release dated May 13, 2026.
- The information in the report is furnished and not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
MicroVision filed an amendment to a previous 8-K to provide omitted financial disclosures regarding the acquisition of Luminar Technologies' advanced LiDAR sensor business. The filing includes audited financial statements of the acquired business and unaudited pro forma combined financial information.
📋 Key Facts
- Acquisition of Luminar Technologies' advanced LiDAR sensor business was completed on February 3, 2026.
- The Asset Purchase Agreement was originally dated January 26, 2026, and amended on February 3, 2026.
- This filing (Amendment No. 1) specifically adds Item 9.01 disclosures, including audited financial statements for the acquired business for fiscal years 2024 and 2025.
- Unaudited pro forma condensed combined financial information as of December 31, 2025, is provided as Exhibit 99.2.
MicroVision, Inc. published an updated investor presentation on April 7, 2026, for use in upcoming meetings with investors and analysts throughout the year. The presentation was furnished under Item 7.01 to comply with Regulation FD and is available on the company's investor relations website.
📋 Key Facts
- The report was filed on April 7, 2026.
- The company published an updated investor presentation (Exhibit 99.1).
- The presentation is intended for use with investors, analysts, and others throughout 2026.
- The information is furnished under Item 7.01 (Regulation FD) and is not deemed 'filed' for purposes of Section 18 of the Exchange Act.
MicroVision, Inc. announced that several members of its board of directors and executive leadership team purchased an aggregate of approximately $310,000 of the company's common stock.
📋 Key Facts
- Transaction date: March 16, 2026
- Total aggregate purchase amount: approximately $310,000
- Participants: Certain members of the Board of Directors and executive officers
- The transaction was disclosed under Item 8.01 (Other Events)
MicroVision, Inc. announced its financial results for the fourth quarter and full year ended December 31, 2025. The results were furnished via a press release on March 4, 2026, as part of a routine quarterly reporting cycle.
📋 Key Facts
- The filing was made on March 4, 2026, to report Q4 and full year 2025 financial results.
- The information was furnished under Item 2.02 (Results of Operations and Financial Condition).
- Exhibit 99.1 contains the detailed press release regarding the company's financial performance.
MicroVision, Inc. announced an upcoming business update and fireside chat featuring CEO Glen DeVos scheduled for February 25, 2026. The company furnished a press release and a video link highlighting the topics to be discussed during the event.
📋 Key Facts
- The event is scheduled for February 25, 2026.
- CEO Glen DeVos will lead the fireside chat.
- The filing includes a press release (Exhibit 99.1) and a video link for investors.
- The information is furnished under Item 7.01 and is not deemed 'filed' for liability purposes.
MicroVision entered into a $43 million senior secured convertible note agreement with an institutional investor to exchange existing 2026 notes and raise new capital. The notes are zero-coupon, mature in 2028, and are secured by a first-priority lien on all company bank and securities accounts.
🚩 Red Flags
- First priority lien on all bank and securities accounts severely limits financial flexibility.
- Strict minimum liquidity covenant of $21.5 million creates high default risk if operations underperform.
- Potential for significant dilution; stockholder approval required to exceed 61,315,970 shares.
- The use of senior secured convertible debt for an asset acquisition suggests limited access to traditional equity or unsecured credit.
📋 Key Facts
- Aggregate principal amount of $43 million in senior secured convertible notes due March 1, 2028.
- Initial conversion price of $0.8819, representing 110% of the last reported sale price on February 23, 2026.
- Notes are secured by a first priority perfected security interest in all bank and securities accounts of the Company.
- Minimum liquidity requirement of the greater of $21.5 million or 110% of the outstanding principal.
- The financing is linked to the acquisition of certain assets from Luminar Technologies, Inc. dated January 26, 2026.
- A cash burn covenant requires available cash to remain above a calculated threshold relative to a reference date minus $25 million.
MicroVision, Inc. has completed the acquisition of certain assets related to Luminar Technologies' lidar sensor business for $33 million in cash.
🚩 Red Flags
- Large cash outlay ($33M) may impact liquidity depending on the company's current cash position (not specified in text).
📋 Key Facts
- Acquisition consummated on February 3, 2026.
- Purchase price is $33,000,000.
- Transaction funded entirely with cash on hand.
- The acquisition involves assets from Luminar Technologies' lidar sensor business.
MicroVision, Inc. has entered into an agreement to acquire certain lidar sensor business assets from Luminar Technologies, Inc., including intellectual property and inventory for Iris and Halo sensors. The acquisition was secured through a competitive auction conducted under Section 363 of the U.S. Bankruptcy Code.
🚩 Red Flags
- Acquisition is being conducted via a bankruptcy auction (Section 363), which can sometimes imply distressed pricing or complex legal contingencies, though it also ensures court oversight.
📋 Key Facts
- Acquisition price is $33,000,000, subject to potential adjustments.
- Assets include intellectual property and inventory related to Luminar's Iris and Halo lidar sensors.
- The acquisition excludes the photonics business of Luminar Semiconductor, Inc.
- MicroVision intends to fund the $33M purchase using current cash on hand.
- The U.S. Bankruptcy Court approved the Asset Purchase Agreement on January 27, 2026.
- MicroVision was selected as the winning bidder in a Section 363 bankruptcy auction.
MicroVision, Inc. received a deficiency notice from Nasdaq because its stock price has fallen below the $1.00 minimum bid price requirement for 30 consecutive business days. The company has 180 days to regain compliance through various methods.
🚩 Red Flags
- Failure to maintain minimum $1.00 bid price requirement (Nasdaq Rule 5450(a)(1))
- Potential for reverse stock split as a remedial action to regain compliance
- Prolonged period of low share price (30 consecutive business days)
📋 Key Facts
- Received notification from Nasdaq on January 12, 2026.
- Deficiency is based on Nasdaq Listing Rule 5450(a)(1) regarding the $1 minimum bid price requirement.
- The company has a 180-day window to regain compliance.
- Current status: The notification does not result in immediate delisting or impact current trading/reporting obligations.
MicroVision, Inc. announced the resignation of its Chief Financial Officer, Anubhav Verma, effective by December 31, 2025. The company has appointed Stephen Hrynewich as Interim CFO and is searching for a permanent replacement.
🚩 Red Flags
- Unexpected departure of a key executive (CFO) during the fiscal year.
- Appointment of an 'Interim' officer suggests potential transition instability or lack of immediate permanent succession planning.
📋 Key Facts
- Anubhav Verma resigned as CFO on November 17, 2025; resignation effective no later than December 31, 2025.
- The company stated the resignation was not due to any disagreement regarding financial statements, internal controls, or operations.
- Stephen Hrynewich (VP, Global Finance & Operations) appointed as Interim CFO, Principal Financial Officer, and Principal Accounting Officer.
- Hrynewich has been with the company since August 2023 and has prior experience at Lucid Group, Republic Services, GM, Nissan, Mazda, and Ford.
MicroVision, Inc. filed an 8-K to announce its third quarter 2025 financial results via a press release. The filing contains no specific financial data or material changes in this text, serving only as a placeholder for the attached exhibit.
📋 Key Facts
- Report date: November 11, 2025
- The company announced its Q3 2025 results via press release (Exhibit 99.1)
- Filing is under Item 2.02 (Results of Operations and Financial Condition)
MicroVision announced a leadership transition where current CTO Glen W. DeVos will become President and CEO effective September 30, 2025, replacing Sumit Sharma. The filing also includes the appointment of Simon Biddiscombe as Executive Vice Chair for a temporary period.
🚩 Red Flags
- Involuntary termination of the current CEO (Sumit Sharma).
- Leadership transition involving a shift in board independence/committee structure (Biddiscombe moving to Executive Vice Chair).
📋 Key Facts
- Glen W. DeVos (current CTO) to become President and CEO on Sept 30, 2025.
- Sumit Sharma will be removed from his role as President and CEO effective Sept 30, 2025; the company characterized this as an 'involuntary termination'.
- DeVos's new compensation includes a $530,000 base salary and a grant of 539,000 RSUs vesting June 6, 2026, contingent on performance.
- Simon Biddiscombe appointed Executive Vice Chair for up to 12 months; he will lose 'independent director' status during this period.
- Robert Carlile appointed as Audit Committee Chair due to Biddiscombe's change in status.
MicroVision, Inc. filed an 8-K to announce the release of its second quarter 2025 financial results. The filing serves as a formal notice that earnings information was made public via press release.
📋 Key Facts
- Report date: August 7, 2025
- Subject matter: Announcement of Q2 2025 results of operations and financial condition
- The report is furnished under Item 2.02 but not 'filed' for purposes of Section 18 liability
- Exhibit 99.1 contains the full press release
MicroVision, Inc. announced a change in its Board of Directors effective July 22, 2025. Laura Peterson has been elected to the Board and appointed to key committee roles, while Dr. Mark Spitzer has retired from the Board.
🚩 Red Flags
- None identified in this filing.
📋 Key Facts
- Laura Peterson was elected to the Board of Directors on July 22, 2025.
- Ms. Peterson appointed as Chair of the Nominating & Governance Committee and a member of the Compensation Committee.
- Dr. Mark Spitzer resigned from the Board effective immediately (July 22, 2025).
- The company stated Dr. Spitzer's retirement was not due to any disagreement regarding operations, policies, or practices.
- Ms. Peterson brings significant experience from Boeing and Palladyne AI Corp.
MicroVision, Inc. announced the approval of its 2025 Executive Bonus Plan and specific equity/bonus incentives for key executives including the CEO, CFO, and General Counsel.
🚩 Red Flags
- Increased short-term incentive percentages for the CFO and General Counsel (from 40% to 65% and 55% respectively) may indicate a push for aggressive financial targets.
📋 Key Facts
- The Compensation Committee approved the 2025 Executive Bonus Plan on June 2, 2025, aimed at performance motivation and retention.
- CFO Anubhav Verma received a short-term incentive bonus opportunity of 65% of base salary and 450,000 RSUs vesting over three years.
- General Counsel Drew Markham received a short-term incentive bonus opportunity of 55% of base salary and 360,000 RSUs vesting over three years.
- CEO Sumit Sharma was granted 1,125,000 RSUs on June 6, 2025, scheduled to vest at 33% annually over three years.
MicroVision, Inc. held its annual meeting of shareholders on June 6, 2025, where shareholders approved a significant increase in the authorized number of shares of common stock and amendments to the equity incentive plan.
🚩 Red Flags
- Significant increase in authorized share count (from previous levels to 510M common shares) often serves as preparation for potential future equity dilution via secondary offerings or warrants.
📋 Key Facts
- Shareholders approved an amendment to increase total authorized capital stock to 535,000,000 shares (comprising 510,000,000 common and 25,000,000 preferred).
- The annual meeting saw a quorum of 161,398,357 shares, representing 65.66% of Common Stock.
- Shareholders approved an amendment to the 2022 Equity Incentive Plan (Proposal 3).
- All seven nominees for the Board of Directors were elected to hold office until the next annual meeting.
- Moss Adams LLP was ratified as the independent registered public accounting firm for fiscal year 2025.
MicroVision, Inc. announced a change in its independent registered public accounting firm following the merger of Moss Adams LLP with Baker Tilly US, LLP. The company has appointed Baker Tilly as its successor auditor.
🚩 Red Flags
- Auditor change (though triggered by a merger rather than a dispute).
📋 Key Facts
- Moss Adams LLP merged with Baker Tilly US, LLP effective June 3, 2025.
- Baker Tilly US, LLP is the successor independent registered public accounting firm.
- The Audit Committee of the Board of Directors approved the appointment of Baker Tilly.
- Audit reports for fiscal years 2023 and 2024 did not contain adverse opinions, disclaimers, or qualifications.
- No disagreements with Moss Adams regarding accounting principles, practices, or auditing scope were reported.
MicroVision, Inc. filed an 8-K to announce the release of its first quarter 2025 financial results. The filing serves as a formal announcement of quarterly earnings performance.
📋 Key Facts
- Report date: May 12, 2025
- Reporting period: First Quarter 2025
- The company issued a press release (Exhibit 99.1) containing the results.
MicroVision, Inc. filed an 8-K to announce its fourth quarter and full year 2024 financial results via a press release.
📋 Key Facts
- Report date: March 26, 2025
- Reporting period: Q4 and Full Year 2024
- The filing is for the purpose of furnishing earnings results under Item 2.02.
MicroVision, Inc. announced the appointment of Glen W. DeVos as the company's new Chief Technology Officer (CTO) on March 24, 2025.
📋 Key Facts
- Appointment of Glen W. DeVos as Chief Technology Officer.
- Announcement date: March 24, 2025.
- The filing includes a press release (Exhibit 99.1) detailing the hire.
MicroVision entered into two significant agreements with High Trail Special Situations LLC: a restructuring of existing $45 million convertible note debt and a new $8 million registered direct offering. The filing details the deferral of cash redemption payments on old debt and the issuance of 5.75 million shares plus warrants to raise immediate capital.
🚩 Red Flags
- Debt restructuring/deferral: The company is deferring nearly $11.55M in redemption payments, indicating potential liquidity constraints to meet original obligations.
- Dilutive financing: Issuance of 5.75 million shares plus warrants represents significant dilution for existing shareholders.
- Convertible debt pressure: Large amounts of principal ($8.725M total) are being converted or deferred, which can lead to downward selling pressure from the investor.
📋 Key Facts
- Entered into a Letter Agreement to restructure $11,550,000 in Partial Redemption Payments originally due June–August 2025; payments are now deferred to Sept 2025–March 2026.
- Investor agreed to convert $2,750,000 of existing principal and use best efforts to convert another $5,975,000 by March 15, 2025.
- Launched a new registered direct offering for approximately $8 million in securities (5,750,225 shares + warrants).
- Warrants issued at an exercise price of $1.57 per share, exercisable after six months or upon Requisite Stockholder Approval.
- The sale is being conducted under a previously effective S-3 registration statement.
MicroVision, Inc. filed an 8-K to announce its third quarter 2024 financial results via a press release. The filing is a standard earnings announcement and does not contain specific material changes or adverse events in the text provided.
📋 Key Facts
- Report date: November 7, 2024
- Subject matter: Announcement of Q3 2024 results
- The filing includes Exhibit 99.1 (Press Release) which contains the actual financial data.
MicroVision announced preliminary third-quarter 2024 results showing a significant year-over-year revenue decline and a substantial decrease in cash reserves. However, the company expects to bolster liquidity through an upcoming $38 million financing tranche.
🚩 Red Flags
- Significant revenue contraction ($1.0M down to <$0.2M YoY).
- Rapid cash burn: Cash reserves dropped by ~$30.8M in 9 months.
- Heavy reliance on equity financing to maintain liquidity (upcoming $38M tranche and large ATM facility).
📋 Key Facts
- Preliminary Q3 2024 revenue: ~$0.15M - $0.2M (vs. $1.0M in Q3 2023).
- Cash and cash equivalents as of Sept 30, 2024: $43.0 million (vs. $73.8M as of Dec 31, 2023).
- Expected net proceeds from a new financing tranche: ~$38.0 million.
- Remaining capacity under existing 'at the market' equity facility: ~$123.0 million.
- Cash used in operations for Q3 2024: ~$14 million (vs. $20M in Q3 2023).
- Active discussions include seven RFQs for passenger vehicles and potential industrial lidar solutions.
MicroVision entered into a Securities Purchase Agreement to issue $45 million in senior secured zero-coupon convertible notes, with an option for an additional $30 million. The notes are secured by a first priority perfected security interest in all bank and securities accounts.
🚩 Red Flags
- Senior Secured Debt: The notes are secured by first priority interest in all bank and securities accounts, effectively subordinating other creditors.
- Potential Dilution: Convertible notes include a conversion feature that could lead to significant share issuance; company must seek stockholder approval for shares exceeding Nasdaq limits.
- Restrictive Covenants: Includes strict liquidity and cash burn requirements that could trigger default if not met.
- High Conversion Premium/Discount Risk: The conversion price mechanisms (120% of last sale or 90% of Nasdaq Minimum) create potential for significant dilution depending on stock performance.
📋 Key Facts
- Initial Principal Amount: $45 million (expected to close October 2024).
- Additional Principal Amount: Up to $30 million, subject to volume and registration conditions.
- Terms: Zero-coupon notes maturing on October 1, 2026.
- Security: First priority perfected security interest in all bank and securities accounts of the Company and subsidiaries.
- Conversion Price: Based on a formula involving 120% of the last reported sale price or 90% of the Nasdaq Minimum Price (whichever is lower).
- Redemption: Holder has options to partially redeem between $1.9M and $3.85M monthly starting Jan 2025.
- Liquidity Covenant: Must maintain minimum liquidity of $30 million (subject to specific adjustments) and a cash burn requirement limiting net cash reduction to $20 million from the reference date.
MicroVision, Inc. announced the retirement of Board member Brian Turner on September 27, 2024. The company explicitly stated that his departure was not due to any disagreement with the company or its operations.
📋 Key Facts
- Brian Turner has retired from the Company's Board of Directors effective September 27, 2024.
- The retirement and resignation were voluntary and not related to any disagreements regarding company operations, policies, or practices.
MicroVision, Inc. filed an 8-K to announce its second quarter 2024 financial results via a press release. The filing is a standard earnings announcement and does not contain material changes to corporate structure or governance.
📋 Key Facts
- Report date: August 7, 2024
- Subject matter: Announcement of Q2 2024 financial results
- The information was furnished pursuant to Item 2.02 and is not considered 'filed' for purposes of Section 18 liability.
MicroVision, Inc. announced that the Board of Directors approved a new employment agreement for CEO Sumit Sharma on July 24, 2024, which supersedes his previous April 2021 agreement.
📋 Key Facts
- New CEO Employment Agreement effective July 24, 2024.
- Base salary remains unchanged at $530,000 per year.
- Includes eligibility for short-term incentive bonus (up to 100% of base salary) tied to financial and individual objectives.
- Grant of 1,125,000 restricted stock units (RSUs) vesting in three annual increments of 33%.
- Agreement includes customary non-solicit and non-compete covenants.
MicroVision, Inc. announced the implementation of a new Key Executive Severance and Change in Control Plan and approved various executive compensation adjustments and bonus plans. The filing also reports results from the company's annual meeting of shareholders held on June 5, 2024.
🚩 Red Flags
- Executive compensation adjustments (salary increases and large RSU grants) during a period where bonuses are being paid in equity rather than cash, which can sometimes indicate liquidity management strategies.
📋 Key Facts
- Effective June 4, 2024, the Company replaced its Prior Severance Plan with the '2024 Severance & CIC Plan'.
- The new plan provides severance up to 18 months of base salary and 150% of target bonus in a Change in Control event.
- CFO Anubhav Verma received a 6.25% base salary increase to $425,000 and was granted 450,000 RSUs vesting over three years.
- General Counsel Drew Markham received a ~7.5% base salary increase to $400,000 and was granted 360,000 RSUs vesting over three years.
- The 2023 short-term incentive bonuses for the CFO and General Counsel were paid in equity (200,000 RSU and 186,250 RSU respectively) instead of cash.
- Shareholders ratified Moss Adams LLP as the independent auditor for fiscal year 2024.
MicroVision, Inc. filed an 8-K to announce its first quarter 2024 financial results via a press release. The filing is a standard earnings announcement and does not contain material changes to corporate structure or governance.
📋 Key Facts
- Report date: May 9, 2024
- Reporting period: First Quarter 2024
- The company issued a press release (Exhibit 99.1) containing the results of operations and financial condition.
MicroVision, Inc. announced an extension of the existing employment agreement for CEO Sumit Sharma. The extension is a temporary measure while a new employment agreement is being negotiated.
🚩 Red Flags
- Negotiation of a new CEO contract can sometimes indicate upcoming changes in compensation structure or potential leadership transition discussions, though not explicitly stated here.
📋 Key Facts
- CEO Sumit Sharma's employment agreement has been extended on April 8, 2024.
- The extension delays the expiration of his current agreement until a new agreement is executed.
- No other terms of the existing employment arrangement were modified or amended.
MicroVision, Inc. entered into a new $150 million At-The-Market (ATM) issuance sales agreement with Deutsche Bank, Mizuho, and Craig-Hallum to raise capital for production scaling and R&D. Simultaneously, the company terminated a previous $35 million ATM agreement with Craig-Hallum.
🚩 Red Flags
- Significant potential dilution due to the $150 million ATM offering.
- The company's forward-looking statements explicitly mention risks regarding 'the ability to operate with limited cash or to raise additional capital when needed'.
📋 Key Facts
- Entered into a new Sales Agreement on March 5, 2024, for up to $150,000,000 in common stock.
- Sales agents include Deutsche Bank Securities Inc., Mizuho Securities USA LLC, and Craig-Hallum Capital Group LLC.
- Agents will receive a 3% commission on gross proceeds in Agency Transactions.
- Terminated a previous $35 million ATM agreement with Craig-Hallum; approximately $16.0 million (6.1 million shares) was previously sold under that agreement.
- Proceeds intended for scaling production with OEM partners, ASIC development, and go-to-market strategy for MAVIN and MOVIA products.
MicroVision, Inc. filed an 8-K to announce its fourth quarter and full year 2023 financial results via a press release. The filing is a routine disclosure of quarterly earnings performance.
📋 Key Facts
- Report date: February 28, 2024
- The company released Q4 and Full Year 2023 financial results.
- Results were communicated via press release (Exhibit 99.1).
- Information was furnished under Item 2.02 but not 'filed' for purposes of Section 18 liability.